Latest Research

This content is currently locked.

Your current Info-Tech Research Group subscription does not include access to this content. Contact your account representative to gain access to Premium SoftwareReviews.

Contact Your Representative
Or Call Us:
1-888-670-8889 (US/CAN) or
+1-519-432-3550 (International)

Comprehensive software reviews to make better IT decisions

COVID-19 Raises Prospects for Robotic Process Automation

Reeling from the pandemic response executed by governments all the over world, companies are accelerating their implementation of low-cost automation. That bodes well for UiPath – a leader in robotic process automation (RPA) aiming to go public this year.

The “great lockdown” has had a dramatic and wildly varying effect across industries. Hospitality is enduring a massive blow and retail is barely limping along, whereas manufacturing is soldiering on and finance is perhaps all but unaffected.

What about healthcare?

Healthcare has predictably experienced feverish activity, whereby hospitals have deployed robots that shine sweeping ultraviolet rays onto every nook and cranny to sterilize wards. They have also deployed software bots to decrease the administrative workload on caregivers. Nurses and medics were thus able to spend more time with patients instead of wasting it on menial tasks.

By being more helpful with patients, healthcare givers effectively became even more valuable to society. Automation augmented their ability rather than stifled their potential.

The silver lining of COVID-19 is its catalytic effect on digital transformation. Companies that have been pondering this concept, planning for it or even making some progress toward it, are now putting it front and center.

Our Take

Ensuring operation resilience has become a top priority for every organization in every industry. Resilience is a byproduct of digital transformation, and RPA is a component of that.

Profitability is a necessary precondition for a successful initial public offering. Therefore, to meet its objective this year, UiPath must show how its product elevates return on human capital, thereby improving net profit margins, and how that has had a positive effect on its own operation.

Want to Know More?

Appian Is Now in the RPA Game With Its Latest Acquisition

There Are So Many RPA Vendors Around; Who Do We Choose?

Blue Prism Releases Learning Edition and Online Learning Platform

Rise of the Robots: Automatons Deployed Alongside Healthcare Workers in the Front-Line Battle Against COVID-19

AI and the Future of Enterprise Productivity
Visit our Exponential IT Research Center
Over 100 analysts waiting to take your call right now: 1-519-432-3550 x2019